Cell Therapy and the Road Ahead for Vision Restoration with Brian Culley
Brian Culley joins Kris Morrill to discuss Lineage Cell Therapeutics’ mission to change the outlook for geographic atrophy with cell therapy. From the long path of drug development to the promise of restoring vision, this episode offers an inside look at where science and business meet in the futur…
Episode 593: Episode 24-39 Covid and 15 Billion Vaccines
On this week’s Tech Nation, Moira speaks with Dr. Antony Taubman, Director of the Intellectual Property Division at the World Trade Organization, about how the world navigated international trade rules to develop and distribute 15 billion doses of Covid vaccine to countries of all economic statuses…
Episode 476: Episode 22-27 The Ford 150 Pick-Up Truck, or rather, Workhorse
On this week’s Tech Nation, Moira speaks with Sandy Fershee, the Lab Director for D-Ford Detroit at Ford Motor Company. They talk about the latest features for the best-selling vehicle on the road - the F-150 pick-up truck from Ford. They talk about the latest design updates, and how Ford went abou…
Episode 401: Episode 21-04 The Ford 150 Pick-Up Truck, or rather Workhorse
On this week’s Tech Nation, Moira speaks with Sandy Fershee, the Lab Director for D-Ford Detroit at Ford Motor Company. They talk about the latest features for the best-selling vehicle on the road - the F-150 pick-up truck from Ford. They talk about the latest design updates, and how Ford went abou…
Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley
We love to hear from our listeners. Send us a message.
On episode 114 of Cell & Gene: The Podcast, Host Erin Harris talks to Brian Culley, CEO of Lineage Cell Therapeutics, about advancing cell therapy beyond oncology and into transformative treatments for conditions such as spinal cord injury and …
319 - Lineage and William Demant Invest Partner to Advance Cell Therapy for Hearing Loss
Can lost hearing cells be replaced? Lineage Cell Therapeutics CEO Brian Culley returns to discuss the company’s new collaboration with William Demant Invest. Together, they’re advancing ReSonance™ (ANP1) — an experimental cell therapy designed to replace damaged auditory neurons and potentially res…
Biopharma CEOs assess the road ahead in 2026
After a turbulent 2025, the biopharma industry is heading into the new year with major questions still unresolved.
A tough biotech investing environment, aggressive direct-to-consumer drug marketing and sweeping U.S. policy changes reshaped the landscape last year. Many of those pressures are expe…
Episode 476: Episode 22-27 The Ford 150 Pick-Up Truck, or rather, Workhorse
On this week’s Tech Nation, Moira speaks with Sandy Fershee, the Lab Director for D-Ford Detroit at Ford Motor Company. They talk about the latest features for the best-selling vehicle on the road - the F-150 pick-up truck from Ford. They talk about the latest design updates, and how Ford went abou…
Episode 401: Episode 21-04 The Ford 150 Pick-Up Truck, or rather Workhorse
On this week’s Tech Nation, Moira speaks with Sandy Fershee, the Lab Director for D-Ford Detroit at Ford Motor Company. They talk about the latest features for the best-selling vehicle on the road - the F-150 pick-up truck from Ford. They talk about the latest design updates, and how Ford went abou…
Building “Off-the-Shelf” Regenerative Cell Therapies: The Next Biotech Revolution | Brian Culley - CEO, Lineage Cell Therapeutics
Send us Fan Mail
Today’s conversation sits at the intersection of one of the most ambitious - and most challenging - frontiers in modern medicine: regenerative cell therapy.For decades, the vision has been incredibly compelling - replace damaged or dying cells with healthy ones, and you could poten…
محرك بحث البودكاست
يمكنك استخدام موقعنا الإلكتروني للبحث في ملفات podcast3,836,284وحلقات197,614,698حسب الأشخاص أو الأماكن أو المواضيع.
الاستثمار في المعرفة يحقق أفضل عائد، ولذلك أستمع إلى البودكاست.
‐ Benjamin "Llamacorn" Franklin
تعديل
شكراً على مساعدتنا في الحفاظ على قاعدة بيانات البودكاست مُحدَّثة.